At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you. The primary responsibility of the Director of Policy is to support Eisai’s engagement with the Centers for Medicare and Medicaid Services (CMS) to secure appropriate access to Eisai products by Medicare beneficiaries. The Director will work across Eisai’s entire portfolio, including in-line and pipeline treatments in Alzheimer’s Disease, neurology, and oncology. In addition, the Director will serve as an internal expert on Medicare Part D policy, Inflation Reduction Act implementation, drug pricing policy, and pharmaceutical industry-directed legislative and regulatory proposals. Further, the Director will help shape internal strategy on policy evolution as well as integration of external policy environment into Eisai’s business planning. Finally, they will serve as Eisai’s representative on key trade association and alliance workgroups to gather and share intelligence, incorporate Eisai’s point of view, and help shape the policy landscape on issues of importance to the company. This function will help shape the policy environment in support of ongoing innovation, patient access, and appropriate reimbursement of company's portfolio. Monitors progress of reimbursement and health policy issues of interest to the company and provides analysis to company officials. Works closely with the Executive Director, Policy to develop overarching US policy strategy to support business needs and patient access imperative. Additional responsibilities will require this position to support cross-functional strategies and communications processes with executive leadership, Eisai senior management, government affairs and advocacy teams, and other Eisai functions. Essential Functions Development and implementation of public policy strategy to address short- and long-term corporate, disease, and brand objectives related to Medicare Part D. Represent Eisai’s patient-focused public policy positions with key external decision makers (policy makers, patient and professional advocacy groups, trade organizations, etc.) where appropriate. Work with BIO and PhRMA on appropriate committees to identify, address and drive issues. Identify, analyze and report on policy and reimbursement initiatives as well as emerging issues that could have a significant impact on Eisai and the biopharmaceutical industry. Work with Eisai business groups to integrate public policy strategies into the Eisai disease, pipeline, and product portfolio. Requirements 4-year college degree, with a minimum of 8 years of biopharmaceutical experience, in government affairs, legislative or public health policy (e.g., public policy affecting pharmaceuticals), or other related positions. Advanced degree preferred. Strong knowledge and experience with Medicare Part D, government price reporting /drug pricing policy, and CMS regulatory processes. Knowledge of or willingness to master additional policy issues impacting the biopharmaceutical industry (e.g., trade, intellectual property). Demonstrated knowledge and understanding of issues affecting the biopharmaceutical and biotechnology industries, Medicare & Medicaid policy, and general health care policy. Strong understanding of public and private payer initiatives affecting reimbursement of biopharmaceutical and biotechnology products. Demonstrated ability to work both independently as a self-motivator across a matrix organization. Strong interpersonal, communication and networking skills. Amenable to travel requirements, including off hour and weekend responsibilities. Eisai Salary Transparency Language: The annual base salary range for the Director, Policy (Hybrid Work Arrangement) is from :$214,700-$281,800 Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan & Eisai Inc. Long Term Incentive Plan. Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills. Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://careers.eisai.com/us/en/compensation-and-benefits. Certain other benefits may be available for this position, please discuss any questions with your recruiter. Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans. Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information: Right To Work E-Verify Participation At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn. All data that is entered should be in the correct case, please refrain from using all caps. For a better user experience, we recommend using the latest version of Chrome.

Director, Policy (Hybrid Work Arrangement).

more at Eisai.

Oncology Sales Specialist- S2 - (White Plains, NY)

Leader, Field and Sales Training, Alzheimer’s Disease

Sr. Oncology Sales Specialist - S1 - (Tacoma, WA) (field based)

similar roles.

Vétérinaire Généraliste F/H

Vétérinaire Généraliste F/H

Open Application

Initiativbewerbung (Festanstellung)

OpenShift Consultant (f/m/d) full-time or part-time

IT Project Manager (f/m/d)